The largest database of trusted experimental protocols

N terminal nanoluc luciferase id1 fusion protein

Manufactured by Genewiz
Sourced in United States

The N-terminal NanoLuc® luciferase ID1 fusion protein is a laboratory tool that combines the NanoLuc® luciferase enzyme with the ID1 protein domain. The NanoLuc® luciferase is a small, bright, and stable luciferase that can be used as a reporter for various biological assays. The ID1 protein domain is a protein involved in cellular processes. This fusion protein allows for the study of the ID1 protein and its interactions within a cellular context.

Automatically generated - may contain errors

2 protocols using n terminal nanoluc luciferase id1 fusion protein

1

NanoBRET Intracellular BET BRD Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A N-terminal NanoLuc® luciferase ID1 fusion protein was synthesized by Genewiz (South Plainfield, NJ, USA) into the pUC57 backbone and then cloned into the pcDNA3.1 plasmid with EcoRI-HF and XbaI (both enzymes from New England Biolabs, Ipswich, MA, USA). The assay was performed essentially as described in the NanoBRET™ TE Intracellular BET BRD Assay kit manual (Promega Corporation, Madison, WI, USA). Briefly cells were transfected and after 24 hours were plated onto flat bottom, non-binding surface, white, polystyrene 96-well plates (Corning Incorporated, Kennebunk, ME, USA). The AGX51 tracer was then added (0–4 μM), followed by digitonin (Sigma, St. Louis, MO, USA) to permeabilize the cells (50 μg/mL). The NanoBRET™ Nano-Glo® Substrate (Promega) was then added and readings taken using a GloMax Discover System instrument (Promega). For the competition assays, cells were treated with 2 μM of AGX51 tracer and 0–60 μM of AGXA or AGX51.
+ Open protocol
+ Expand
2

NanoBRET Intracellular BET BRD Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A N-terminal NanoLuc® luciferase ID1 fusion protein was synthesized by Genewiz (South Plainfield, NJ, USA) into the pUC57 backbone and then cloned into the pcDNA3.1 plasmid with EcoRI-HF and XbaI (both enzymes from New England Biolabs, Ipswich, MA, USA). The assay was performed essentially as described in the NanoBRET™ TE Intracellular BET BRD Assay kit manual (Promega Corporation, Madison, WI, USA). Briefly cells were transfected and after 24 hours were plated onto flat bottom, non-binding surface, white, polystyrene 96-well plates (Corning Incorporated, Kennebunk, ME, USA). The AGX51 tracer was then added (0–4 μM), followed by digitonin (Sigma, St. Louis, MO, USA) to permeabilize the cells (50 μg/mL). The NanoBRET™ Nano-Glo® Substrate (Promega) was then added and readings taken using a GloMax Discover System instrument (Promega). For the competition assays, cells were treated with 2 μM of AGX51 tracer and 0–60 μM of AGXA or AGX51.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!